These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10425338)

  • 21. In vitro and in vivo evaluation of two extended release preparations of combination metformin and glipizide.
    Defang O; Shufang N; Wei L; Hong G; Hui L; Weisan P
    Drug Dev Ind Pharm; 2005 Aug; 31(7):677-85. PubMed ID: 16207615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Asymmetric membrane capsules for osmotic drug delivery II. In vitro and in vivo drug release performance.
    Thombre AG; Cardinal JR; DeNoto AR; Gibbes DC
    J Control Release; 1999 Jan; 57(1):65-73. PubMed ID: 9863040
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Asymmetric membrane capsule for osmotic delivery of flurbiprofen.
    Choudhury PK; Ranawat MS; Pillai MK; Chauhan CS
    Acta Pharm; 2007 Sep; 57(3):343-50. PubMed ID: 17878113
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclodextrin complex osmotic tablet for glipizide delivery.
    Gan Y; Pan W; Wei M; Zhang R
    Drug Dev Ind Pharm; 2002 Sep; 28(8):1015-21. PubMed ID: 12378956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation of a push-pull osmotic pump of felodipine solubilized by mesoporous silica nanoparticles with a core-shell structure.
    Wu C; Zhao Z; Zhao Y; Hao Y; Liu Y; Liu C
    Int J Pharm; 2014 Nov; 475(1-2):298-305. PubMed ID: 25148731
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selection of excipients for extended release formulations of glipizide through drug-excipient compatibility testing.
    Verma RK; Garg S
    J Pharm Biomed Anal; 2005 Jul; 38(4):633-44. PubMed ID: 15967291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Technological and pharmacotherapeutic properties of selected drugs with modified release of diclofenac sodium].
    Kołodziejczyk MK; Kołodziejska J; Zgoda MM
    Polim Med; 2012; 42(2):121-32. PubMed ID: 23016443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Osmotic flow through asymmetric membrane: a means for controlled delivery of drugs with varying solubility.
    Philip AK; Pathak K
    AAPS PharmSciTech; 2006 Jul; 7(3):56. PubMed ID: 17025237
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of hydroxypropyl methylcellulose matrix systems as swellable gastro-retentive drug delivery systems (GRDDS).
    Matharu AS; Motto MG; Patel MR; Simonelli AP; Dave RH
    J Pharm Sci; 2011 Jan; 100(1):150-63. PubMed ID: 20572054
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Asymmetric Membrane Capsules for Extended Delivery of the Weakly Basic Drug Carvedilol.
    Guarve K; Gupta GD
    Pharmaceutics; 2010 May; 2(2):199-208. PubMed ID: 27721351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigating the coating-dependent release mechanism of a pulsatile capsule using NMR microscopy.
    Sutch JC; Ross AC; Köckenberger W; Bowtell RW; MacRae RJ; Stevens HN; Melia CD
    J Control Release; 2003 Oct; 92(3):341-7. PubMed ID: 14568414
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Propranolol hydrochloride osmotic capsule with controlled onset of release.
    Barzegar-Jalali M; Adibkia K; Mohammadi G; Zeraati M; Bolagh BA; Nokhodchi A
    Drug Deliv; 2007 Oct; 14(7):461-8. PubMed ID: 17994364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A water-insoluble drug monolithic osmotic tablet system utilizing gum arabic as an osmotic, suspending and expanding agent.
    Lu EX; Jiang ZQ; Zhang QZ; Jiang XG
    J Control Release; 2003 Oct; 92(3):375-82. PubMed ID: 14568418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase Transited Asymmetric Membrane Capsule: A Means for Achieving Delayed and Controlled Osmotic Flow.
    Philip AK; Philip B
    Curr Drug Deliv; 2010 Jul; 7(3):230-7. PubMed ID: 20497101
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative evaluation of drug release from aged prolonged polyethylene oxide tablet matrices: effect of excipient and drug type.
    Shojaee S; Kaialy W; Cumming KI; Nokhodchi A
    Pharm Dev Technol; 2016 Mar; 21(2):189-95. PubMed ID: 25410967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Osmotic delivery of flurbiprofen through controlled porosity asymmetric membrane capsule.
    Choudhury PK; Chauhan CS; Ranawat MS
    Drug Dev Ind Pharm; 2007 Oct; 33(10):1135-41. PubMed ID: 17963115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Development of glipizide push-pull osmotic pump controlled release tablets by using expert system and artificial neural network].
    Zhang ZH; Wang Y; Wu WF; Zhao X; Sun XC; Wang HQ
    Yao Xue Xue Bao; 2012 Dec; 47(12):1687-95. PubMed ID: 23460977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro evaluation of extemporaneously compounded immediate-release capsules with premixed excipients, based on the biopharmaceutics classification system (BCS) of the drugs.
    Pinheiro VA; Danopoulos P; Demirdjian L; Nogueira RJ; Dubois F
    Int J Pharm Compd; 2013; 17(5):424-31. PubMed ID: 24459788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent advances in asymmetric membrane capsule based osmotic pump: a patent overview.
    Patel A; Mehta T; Patel J; Patel M; Patel K; Patel N
    Recent Pat Drug Deliv Formul; 2012 Apr; 6(1):66-72. PubMed ID: 22191697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inlay osmotic pump tablets containing metformin and glipizide.
    Patel RB; Patel GN; Patel HR; Patel MM
    Drug Dev Ind Pharm; 2011 Oct; 37(10):1244-52. PubMed ID: 21466414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.